Examination of the TCGA dataset for IDH wild-type glioblastoma also showed a wide variation in the expression levels of BCAT1, with A11 representative of tumors with high expression and S2 tumors with low expression (Figure 1H). This evidence concerns the gene IDH1 and glioblastoma.